Clinical Trial Update: A Study of CNA3103 (LGR5-targeted, Autologous CAR-T Cells) Administered to Subjects With Metastatic Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for CNA3103, a LGR5-targeted autologous CAR-T therapy, being evaluated in Phase 1/2 for metastatic colorectal cancer. Recruitment is ongoi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• CNA3103 (LGR5-targeted autologous CAR-T cells)

Snippet

Sponsor: Carina Biotech Limited | Conditions: Colorectal Cancer Metastatic | Phase 1, Phase 2 | Status: RECRUITING